These results suggested that upregulation of PAR2 signaling, via modulating the expression of BDNF, critically participated in the induction of enhanced spinal glutamatergic transmission and pain behavior in the rats with bone cancer. The gene discussed is BDNF; the disease is bone neoplasm.